Finastelad Driada Medical
| Features | |
| Active substance | Finasteride |
| Also known as | MK-906 |
| Blood pressure | No significant effect on blood pressure |
| Category | Categories |
| Chemical name | N-(1,1-dimethylethyl)-3-oxo-4-aza-5О±-androst-1-ene-17ОІ-carboxamide |
| Dosage | 1 Mg |
| Dosage (medical) | 1 mg daily for androgenetic alopecia, 5 mg daily for benign prostatic hyperplasia |
| Dosage (sports) | Not typically used in sports for performance enhancement |
| Dosage Unit | Tabs |
| ean13 | 1375177128703 |
| Effects | Reduces serum and scalp dihydrotestosterone (DHT) levels |
| FORM | Oral |
| Formula | C23H36N2O2 |
| Half-life | 5-6 hours |
| Hepatotoxicity | Low risk of hepatotoxicity |
| Lab Test | May affect PSA (prostate-specific antigen) levels |
| Main action | Inhibits the enzyme 5О±-reductase |
| Reference | DRI22 |
| Side effects | Decreased libido, erectile dysfunction, ejaculation disorders, breast tenderness and enlargement |
| Storage conditions | Store at room temperature, protect from moisture and light |
| Substance class | 5О±-reductase inhibitor |
| Tab Piece | 50 Tabs |
| Trade name | Proscar, Propecia |
| Use in sports | Not commonly used for sports performance, may be used by athletes to control hair loss |
| Water Retention | No significant effect on water retention |
| Packing | Blister |